Search Results

Containing any of the words

Only of the type

A Phase II, Multi-centre Open Label Study to Assess the Efficacy and Safety of Oral Apabetalone with Background Dapagliflozin in Subjects with Long -COVID-19 (Post-COVID-19 Conditions) and Type 2 Diabetes Mellitus (T2DM) Drug Clinical Trial

Phase 3 Randomized Study Comparing Talquetamab in Combination with Pomalidomide (Tal-P), Talquetamab in Combination with Teclistamab (Tal-Tec), and Investigator’s Choice of Either Elotuzumab, Pomalidomide, and Dexamethasone (EPd) or Pomalidomide, Bortezomib, and Dexamethasone (PVd) in Participants with Relapsed or Refractory Myeloma who Have Received 1 to 4 Prior Lines of Therapy Including an Anti-CD38 Antibody and Lenalidomide Drug Clinical Trial

Efficacy and Safety of “DeflaGyn Vaginal Gel” Clinical Trial

Efficacy and Safety of “DeflaGyn Vaginal Gel” Clinical Trial

Efficacy and Safety of “DeflaGyn Vaginal Gel” Clinical Trial

Efficacy and Safety of “DeflaGyn Vaginal Gel” Clinical Trial

Efficacy and Safety of “DeflaGyn Vaginal Gel” Clinical Trial

Efficacy and Safety of “DeflaGyn Vaginal Gel” Clinical Trial

CLEAR (DeflaGyn Vaginal Gel) Clinical Trial

A Phase III, Multicenter, Randomized, parallel-group study to asses the efficacy and saftey of double-blind pasireotide LAR 40 mg and pasireotide LAR 60 mg versus open lable octreotide LAR or lanreotide ATG in patients with inadequately controlled acromegaly. Drug Clinical Trial